Author: OurCrowd

[Colossal in BusinessWire] Colossal Biosciences and Save the Elephants debut first-of-its-kind project to utilize drones and machine learning for elephant conservation

Nov 9, 2023 |

DALLAS–(BUSINESS WIRE)–Colossal Biosciences, the world’s first de-extinction and species preservation company, has partnered with Save the Elephants, a leading non-profit that works to secure a future for wild African elephants, on a first-of-its-kind initiative that will use cutting edge drone technology and machine learning to help track African elephants in Kenya for both conservation and research purposes. Read more...

Read More

[OurCrowd in The Jerusalem Post] Medved: Despite all odds, ‘the tech community is fully mobilized’

Nov 9, 2023 | ,

Israel’s hi-tech sector, a stalwart of the nation’s economy, is showcasing resilience in the ongoing conflict, as noted by OurCrowd CEO Jon Medved during a press event held Wednesday night. Despite the challenges, the tech community remains fully mobilized, contributing significantly to stability and functionality during these testing times. Read more...

Read More

[Sequentify in PR Newswire] Stanford to use Sequentify kits for Hematological Malignancies NGS Sequencing

Nov 8, 2023 |

REHOVOT, Israel, Nov. 8, 2023 /PRNewswire/ — Sequentify, a Weizmann Institute spinoff that develops synthetic biology and AI software to enable rapid targeted DNA sequencing, is pleased to announce Stanford Institute for Stem Cell Biology and Regenerative Medicine will be using its NGS targeted panels for acute myeloid leukemia (AML) somatic mutation detection. Applications include basic and translational research into AML pathogenesis and novel therapeutic target identification. Read more...

Read More